Shanghai Runda Med Tech Co (603108) — Cash Flow Reinvestment Rate

Latest as of June 2023: 0.50x

Shanghai Runda Med Tech Co (603108) has a Cash Flow Reinvestment Rate of 0.50x as of June 2023, reinvesting CN¥71.74 Million (capex CN¥68.54 Million plus investments CN¥-3.20 Million) from operating cash flow of CN¥144.38 Million. Check 603108 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.50x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥71.74 Million
Capex + Investments

Operating Cash Flow

CN¥144.38 Million
CNY

Capital Expenditures

CN¥68.54 Million
CNY

Shanghai Runda Med Tech Co Cash Flow Reinvestment Rate (2014–2024)

Historical reinvestment intensity for Shanghai Runda Med Tech Co across 7 annual periods. Explore Shanghai Runda Med Tech Co (603108) long-term investment share to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Shanghai Runda Med Tech Co (2014–2024)

Year-by-year capital reinvestment analysis for Shanghai Runda Med Tech Co. For live market cap and broader valuation context, see 603108 market cap.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 1.07x CN¥689.83 Million CN¥646.95 Million CN¥229.16 Million ▲ +42.2%
2023 0.75x CN¥547.22 Million CN¥729.72 Million CN¥319.88 Million ▼ -8.0%
2021 0.82x CN¥302.47 Million CN¥371.11 Million CN¥301.09 Million ▼ -58.7%
2020 1.97x CN¥638.19 Million CN¥323.44 Million CN¥331.94 Million ▲ +60.2%
2019 1.23x CN¥303.75 Million CN¥246.68 Million CN¥288.73 Million ▲ +92.4%
2018 0.64x CN¥344.92 Million CN¥538.90 Million CN¥264.43 Million ▼ -81.6%
2014 3.47x CN¥125.35 Million CN¥36.11 Million CN¥125.35 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow